The market for breast biopsy is expected to grow at a CAGR of around 7.4% from 2020 to 2027 and expected to reach the market value of around US$ 1,296 Mn by 2027.
Breast biopsy is a medical procedure during that a sample of breast tissue is removed and sent to a laboratory for testing. The procedure is best suitable for evaluating breast if it has lumps or the portion of it is cancerous. The sample is used by doctors to identify and diagnose abnormalities in the cells that make up breast lumps, other unusual breast changes, or suspicious or concerning findings on a mammogram or ultrasound. Moreover, the risks associated with the breast biopsy include bruising and swelling of the breast, infection or bleeding at the biopsy site, and altered breast appearance.
Market Dynamics
The growing incidence of breast cancer due to changing women's lifestyles is driving the market growth. The increasing number of breast cancer screening programs simultaneously increasing demand for minimally invasive and non-invasive procedures is accelerating the market growth. The growing awareness regarding early detection of breast cancer as well as improved reimbursement scenario is bolstering the market value. Furthermore, emerging economies offer high growth potential, the emergence of liquid biopsy and promising clinical trials, and increasing public-private investments and funding are the factors projected to create potential opportunities over the forecast period from 2020 to 2027.
On the other side, the risk of infections associated with the use of biopsy needles and stringent regulatory approval procedures are projected to hinder the growth during the forecast timeframe from 2020 to 2027.
Segment Instance of Global Breast Biopsy Market
North America accounted for the maximum revenue share in the global market
In 2019, North America is leading the breast biopsy market owing to its highly developed infrastructure and awareness among women about the procedures. The US accounted for the dominating share (%) in the regional market. According to the American Cancer Society and the National Cancer Institute estimated of 2018, over 265,000 new cases of invasive breast cancer were diagnosed among women in the US, with 63,960 new cases of non-invasive (in situ) breast cancer. Moreover, one in eight women develops invasive breast cancer for her lifetime in the US.
Asia Pacific is anticipated to exhibit fastest growth over the forecast period from 2020 to 2027
Asia Pacific region along with its major economies is expected to experience the fastest growth over the forecast period from 2020 to 2027. The developing healthcare infrastructure, increasing discretionary income, rising awareness among women about the procedure, and increasing investment by the regional players are driving the market growth. The increasing number of hospitals are focusing on the advancement of their infrastructure by including advanced products for serving people with effective and efficient Guidance.
Prominent Market Players
The players profiled in the report include Argon Medical Devices, Becton and Dickinson Company, Cook Medical Incorporated, Danaher Corporation, Encapsule medical Devices LLC., Ethicon Endo Surgery (Johnson & Johnson), Gallini SRL, Hologic Inc., Intact Medical Corporation, Medtronic, Thermo Fisher Scientific, Inc., and F. Hoffmann-La Roche Ltd.
Market Segmentation
Market By Product
Biopsy Needles
Guidance Systems
Biopsy Tables
Localization Wires
Assay Kits
Liquid Biopsy Instruments
Others
Market By Type
Needle Breast Biopsy
- Core Needle Biopsy (CNB)
- Fine Needle Aspiration Biopsy (FNAB)
- Vacuum-assisted Biopsy (VAB)
Open Surgical Breast Biopsy
Liquid Breast Biopsy
- Circulating Tumor Cells
- Circulating Tumor DNA (ctDNA)
- Other Biomarkers
Market By Guidance
Image-Guided Biopsy
- Mammography-guided Stereotactic Biopsy
- Ultrasound-guided Biopsy
- MRI-guided Biopsy
- Other Guidance Techniques
Liquid Biopsy
- NGS-based Biopsy
- PCR-based Biopsy
- Microarray-based Biopsy
Market By Application
Early Cancer Screening
Therapy Selection
Treatment Monitoring
Recurrence Monitoring
Market By Geography
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Breast Biopsy
1.1. Definition and Scope
1.1.1. Definition of Breast Biopsy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Breast Biopsy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Breast Biopsy Market By Product
1.2.3. Breast Biopsy Market By Type
1.2.4. Breast Biopsy Market By Guidance
1.2.5. Breast Biopsy Market By Application
1.2.6. Breast Biopsy Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Breast Biopsy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Breast Biopsy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Breast Biopsy Market By Product
4.1. Introduction
4.2. Breast Biopsy Revenue By Product
4.2.1. Breast Biopsy Revenue (US$ Mn) and Forecast, By Product, 2016-2027
4.2.2. Biopsy Needles
4.2.2.1. Biopsy Needles Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Guidance Systems
4.2.3.1. Guidance Systems Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Biopsy Tables
4.2.4.1. Biopsy Tables Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.5. Localization Wires
4.2.5.1. Localization Wires Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.6. Assay Kits
4.2.6.1. Assay Kits Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.7. Liquid Biopsy Instruments
4.2.7.1. Liquid Biopsy Instruments Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.8. Others
4.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Breast Biopsy Market By Type
5.1. Introduction
5.2. Breast Biopsy Revenue By Type
5.2.1. Breast Biopsy Revenue (US$ Mn) and Forecast, By Type, 2016-2027
5.2.2. Needle Breast Biopsy
5.2.2.1. Needle Breast Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.1. Core Needle Biopsy (CNB)
5.2.2.1.1.1. Core Needle Biopsy (CNB) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.2. Fine Needle Aspiration Biopsy (FNAB)
5.2.2.1.2.1. Fine Needle Aspiration Biopsy (FNAB) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.2.1.3. Vacuum-assisted Biopsy (VAB)
5.2.2.1.3.1. Vacuum-assisted Biopsy (VAB) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Open Surgical Breast Biopsy
5.2.3.1. Open Surgical Breast Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.1.1. Excisional
5.2.3.1.1.1. Excisional Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3.1.2. Incisional
5.2.3.1.2.1. Incisional Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Liquid Breast Biopsy
5.2.4.1. Liquid Breast Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4.1.1. Circulating Tumor Cells
5.2.4.1.1.1. Circulating Tumor Cells Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4.1.2. Circulating Tumor DNA (CtDNA)
5.2.4.1.2.1. Circulating Tumor DNA (CtDNA) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4.1.3. Other Biomarkers
5.2.4.1.3.1. Other Biomarkers Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Breast Biopsy Market Revenue By Guidance
6.1. Introduction
6.2. Breast Biopsy Revenue (US$ Mn) By Guidance
6.2.1. Breast Biopsy Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
6.2.2. Image-Guided Biopsy
6.2.2.1. Image-Guided Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.1. Mammography-guided Stereotactic Biopsy
6.2.2.1.1.1. Mammography-guided Stereotactic Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.2. Ultrasound-guided Biopsy
6.2.2.1.2.1. Ultrasound-guided Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.3. MRI-guided Biopsy
6.2.2.1.3.1. MRI-guided Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.2.1.4. Other Guidance Techniques
6.2.2.1.4.1. Other Guidance Techniques Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Liquid Biopsy
6.2.3.1. Liquid Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.1. NGS-based Biopsy
6.2.3.1.1.1. NGS-based Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.2. PCR-based Biopsy
6.2.3.1.2.1. PCR-based Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3.1.3. Microarray-based Biopsy
6.2.3.1.3.1. Microarray-based Biopsy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. Breast Biopsy Market By Application
7.1. Introduction
7.2. Breast Biopsy Revenue (US$ Mn) By Application
7.2.1. Breast Biopsy Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
7.2.2. Early Cancer Screening
7.2.2.1. Early Cancer Screening Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3. Therapy Selection
7.2.3.1. Therapy Selection Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.4. Treatment Monitoring
7.2.4.1. Treatment Monitoring Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.5. Recurrence Monitoring
7.2.5.1. Recurrence Monitoring Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America Breast Biopsy Market By Country
8.1. North America Breast Biopsy Overview
8.2. U.S.
8.2.1. U.S. Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.2.2. U.S. Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.3. U.S. Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016-2027
8.2.4. U.S. Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.3. Canada
8.3.1. Canada Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
8.3.2. Canada Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.3. Canada Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016-2027
8.3.4. Canada Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe Breast Biopsy Market By Country
9.1. Europe Breast Biopsy Market Overview
9.2. U.K.
9.2.1. U.K. Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.2.2. U.K. Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.2.3. U.K. Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016-2027
9.2.4. U.K. Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.3. Germany
9.3.1. Germany Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.3.2. Germany Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.3.3. Germany Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016-2027
9.3.4. Germany Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.4. France
9.4.1. France Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.4.2. France Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.4.3. France Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016-2027
9.4.4. France Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.5. Spain
9.5.1. Spain Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.5.2. Spain Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.5.3. Spain Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016-2027
9.5.4. Spain Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
9.6.2. Rest of Europe Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
9.6.3. Rest of Europe Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016-2027
9.6.4. Rest of Europe Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Breast Biopsy Market By Country
10.1. Asia Pacific Breast Biopsy Market Overview
10.2. China
10.2.1. China Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.2.2. China Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.3. China Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
10.2.4. China Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. Japan
10.3.1. Japan Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.3.2. Japan Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.3. Japan Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
10.3.4. Japan Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. India
10.4.1. India Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.4.2. India Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.3. India Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
10.4.4. India Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.5. Australia
10.5.1. Australia Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.5.2. Australia Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.5.3. Australia Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
10.5.4. Australia Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.6. South Korea
10.6.1. South Korea Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.6.2. South Korea Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.6.3. South Korea Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
10.6.4. South Korea Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
10.7.2. Rest of Asia-Pacific Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.7.3. Rest of Asia-Pacific Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
10.7.4. Rest of Asia-Pacific Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Breast Biopsy Market By Country
11.1. Latin America Breast Biopsy Market Overview
11.2. Brazil
11.2.1. Brazil Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
11.2.2. Brazil Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.3. Brazil Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
11.2.4. Brazil Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.3. Mexico
11.3.1. Mexico Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
11.3.2. Mexico Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.3. Mexico Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
11.3.4. Mexico Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
11.4.2. Rest of Latin America Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.3. Rest of Latin America Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
CHAPTER 12. Middle East & Africa Breast Biopsy Market By Country
12.1. Middle East & Africa Breast Biopsy Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
12.2.2. Saudi Arabia Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.2.3. Saudi Arabia Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
12.2.4. Saudi Arabia Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.3. UAE
12.3.1. UAE Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
12.3.2. UAE Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.3.3. UAE Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
12.3.4. UAE Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Breast Biopsy Market Revenue (US$ Mn) and Forecast By Product, 2016-2027
12.4.2. Rest of Middle East & Africa Breast Biopsy Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
12.4.3. Rest of Middle East & Africa Breast Biopsy Market Revenue (US$ Mn) and Forecast By Guidance, 2016 - 2027
12.4.4. Rest of Middle East & Africa Breast Biopsy Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
CHAPTER 13. Player Analysis Of Breast Biopsy
13.1. Breast Biopsy Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Breast Biopsy Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. COMPANY PROFILE
14.1. Argon Medical Devices
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Argon Medical Devices 2019 Breast Biopsy Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Becton and Dickinson Company
14.3. Cook Medical Incorporated
14.4. Danaher Corporation
14.5. Encapsule Medical Devices LLC.
14.6. Ethicon Endo Surgery (Johnson & Johnson)
14.7. Gallini SRL
14.8. Hologic Inc.
14.9. Intact Medical Corporation
14.10. Medtronic
14.11. Thermo Fisher Scientific, Inc.
14.12. F. Hoffmann-La Roche Ltd.
14.13. Others
